Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weixing Guo

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Oncotarget|June 1, 2018
Should transarterial chemoembolization be given before or after intensity-modulated radiotherapy to treat patients with hepatocellular carcinoma with portal vein tumor thrombus? a propensity score matching studyXiaolong Li, Weixing Guo, Lei Guo, et al.
International Journal of Biological Sciences|April 4, 2017
PKD knockdown inhibits pressure overload-induced cardiac hypertrophy by promoting autophagy via AKT/mTOR pathwayDi Zhao, Wei Wang, Hao Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 30, 2010
Expression of the chemokine receptor CXCR4 in human hepatocellular carcinoma and its role in portal vein tumor thrombusNan Li, Weixing Guo, Jie Shi, et al.
Oncotarget|January 16, 2016
Gene copy number variations in the leukocyte genome of hepatocellular carcinoma patients with integrated hepatitis B virus DNAYanan Pang, Weixing Guo, Jiaqi Wang, et al.
Scientific Reports|December 24, 2016
Circulating tumor cell detection in hepatocellular carcinoma based on karyoplasmic ratios using imaging flow cytometryZixin Liu, Weixing Guo, Dandan Zhang, et al.
Hepatology International|October 21, 2022
Radiotherapy prior to or after transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a randomized controlled trialLei Guo, Xubiao Wei, Shuang Feng, et al.
Oncotarget|February 25, 2016
14-3-3ζ promotes hepatocellular carcinoma venous metastasis by modulating hypoxia-inducible factor-1αYufu Tang, Shupeng Liu, Nan Li, et al.
Experimental and Therapeutic Medicine|July 3, 2015
Cidan inhibits liver cancer cell growth by reducing COX-2 and VEGF expression and cell cycle arrestNan Li, Donghai Zheng, Jie Xue, et al.
Journal of Proteome Research|June 30, 2010
Proteomics analysis of distinct portal vein tumor thrombi in hepatocellular carcinoma patientsWeixing Guo, Jie Xue, Jie Shi, et al.
Molecular Oncology|November 6, 2020
Loss of STAT5A promotes glucose metabolism and tumor growth through miRNA-23a-AKT signaling in hepatocellular carcinomaYabo Jiang, Yongzhen Tao, Xiuping Zhang, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Oncotarget|June 1, 2018
Should transarterial chemoembolization be given before or after intensity-modulated radiotherapy to treat patients with hepatocellular carcinoma with portal vein tumor thrombus? a propensity score matching studyXiaolong Li, Weixing Guo, Lei Guo, et al.
International Journal of Biological Sciences|April 4, 2017
PKD knockdown inhibits pressure overload-induced cardiac hypertrophy by promoting autophagy via AKT/mTOR pathwayDi Zhao, Wei Wang, Hao Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 30, 2010
Expression of the chemokine receptor CXCR4 in human hepatocellular carcinoma and its role in portal vein tumor thrombusNan Li, Weixing Guo, Jie Shi, et al.
Oncotarget|January 16, 2016
Gene copy number variations in the leukocyte genome of hepatocellular carcinoma patients with integrated hepatitis B virus DNAYanan Pang, Weixing Guo, Jiaqi Wang, et al.
Scientific Reports|December 24, 2016
Circulating tumor cell detection in hepatocellular carcinoma based on karyoplasmic ratios using imaging flow cytometryZixin Liu, Weixing Guo, Dandan Zhang, et al.
Hepatology International|October 21, 2022
Radiotherapy prior to or after transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a randomized controlled trialLei Guo, Xubiao Wei, Shuang Feng, et al.
Oncotarget|February 25, 2016
14-3-3ζ promotes hepatocellular carcinoma venous metastasis by modulating hypoxia-inducible factor-1αYufu Tang, Shupeng Liu, Nan Li, et al.
Experimental and Therapeutic Medicine|July 3, 2015
Cidan inhibits liver cancer cell growth by reducing COX-2 and VEGF expression and cell cycle arrestNan Li, Donghai Zheng, Jie Xue, et al.
Journal of Proteome Research|June 30, 2010
Proteomics analysis of distinct portal vein tumor thrombi in hepatocellular carcinoma patientsWeixing Guo, Jie Xue, Jie Shi, et al.
Molecular Oncology|November 6, 2020
Loss of STAT5A promotes glucose metabolism and tumor growth through miRNA-23a-AKT signaling in hepatocellular carcinomaYabo Jiang, Yongzhen Tao, Xiuping Zhang, et al.
Pageof 4